OWENS & MINOR INC (OMI) Stock Fundamental Analysis
NYSE:OMI - New York Stock Exchange, Inc. - US6907321029 - Common Stock - Currency: USD
Overall OMI gets a fundamental rating of 4 out of 10. We evaluated OMI against 108 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. OMI may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year OMI was profitable.
OMI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
Each year in the past 5 years OMI had a positive operating cash flow.
1.2 Ratios
OMI has a Return On Assets (-0.96%) which is comparable to the rest of the industry.
OMI's Return On Equity of -5.58% is in line compared to the rest of the industry. OMI outperforms 49.53% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.98%, OMI is in the better half of the industry, outperforming 70.09% of the companies in the same industry.
OMI had an Average Return On Invested Capital over the past 3 years of 8.85%. This is in line with the industry average of 8.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -5.58% | ||
| ROIC | 6.98% |
ROA(3y)1.96%
ROA(5y)1.01%
ROE(3y)7.17%
ROE(5y)2.44%
ROIC(3y)8.85%
ROIC(5y)7.96%
1.3 Margins
OMI's Operating Margin of 2.61% is in line compared to the rest of the industry. OMI outperforms 52.34% of its industry peers.
In the last couple of years the Operating Margin of OMI has grown nicely.
The Gross Margin of OMI (20.72%) is worse than 62.62% of its industry peers.
In the last couple of years the Gross Margin of OMI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 20.72% |
OM growth 3Y3.01%
OM growth 5Y19.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y12.59%
2. Health
2.1 Basic Checks
OMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, OMI has more shares outstanding
OMI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OMI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.48 indicates that OMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.48, OMI perfoms like the industry average, outperforming 57.01% of the companies in the same industry.
OMI has a Debt/Equity ratio of 2.11. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.11, OMI is not doing good in the industry: 78.50% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.48 |
ROIC/WACC0.98
WACC7.14%
2.3 Liquidity
OMI has a Current Ratio of 1.09. This is a normal value and indicates that OMI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, OMI is doing worse than 73.83% of the companies in the same industry.
OMI has a Quick Ratio of 1.09. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.45, OMI is not doing good in the industry: 93.46% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 74.74% over the past year.
OMI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.23% yearly.
The Revenue has been growing slightly by 4.22% in the past year.
Measured over the past years, OMI shows a small growth in Revenue. The Revenue has been growing by 1.87% on average per year.
EPS 1Y (TTM)74.74%
EPS 3Y-14.68%
EPS 5Y3.23%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)4.22%
Revenue growth 3Y6.81%
Revenue growth 5Y1.87%
Sales Q2Q%4.95%
3.2 Future
The Earnings Per Share is expected to grow by 15.52% on average over the next years. This is quite good.
Based on estimates for the next years, OMI will show a small growth in Revenue. The Revenue will grow by 5.38% on average per year.
EPS Next Y11.12%
EPS Next 2Y15.15%
EPS Next 3Y21.66%
EPS Next 5Y15.52%
Revenue Next Year3.37%
Revenue Next 2Y3.58%
Revenue Next 3Y3.61%
Revenue Next 5Y5.38%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 3.75 indicates a rather cheap valuation of OMI.
99.07% of the companies in the same industry are more expensive than OMI, based on the Price/Earnings ratio.
OMI is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 3.45, the valuation of OMI can be described as very cheap.
99.07% of the companies in the same industry are more expensive than OMI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of OMI to the average of the S&P500 Index (22.68), we can say OMI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.75 | ||
| Fwd PE | 3.45 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, OMI is valued cheaper than 98.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.25 |
4.3 Compensation for Growth
OMI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OMI's earnings are expected to grow with 21.66% in the coming years.
PEG (NY)0.34
PEG (5Y)1.16
EPS Next 2Y15.15%
EPS Next 3Y21.66%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.22
-0.18 (-2.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.91%
Inst Owner Change-2.31%
Ins Owners2.2%
Ins Owner Change0.57%
Market Cap479.62M
Analysts48.33
Price Target16.83 (170.58%)
Short Float %6.16%
Short Ratio5.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.67%
Min EPS beat(2)0.62%
Max EPS beat(2)8.73%
EPS beat(4)4
Avg EPS beat(4)4.36%
Min EPS beat(4)0.62%
Max EPS beat(4)8.73%
EPS beat(8)7
Avg EPS beat(8)19.7%
EPS beat(12)10
Avg EPS beat(12)15.73%
EPS beat(16)14
Avg EPS beat(16)19.81%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)0.52%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)9
Avg Revenue beat(16)0.97%
PT rev (1m)1.02%
PT rev (3m)-16.46%
EPS NQ rev (1m)-1.4%
EPS NQ rev (3m)-6.46%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)-1.63%
Revenue NQ rev (3m)-1.85%
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.75 | ||
| Fwd PE | 3.45 | ||
| P/S | 0.04 | ||
| P/FCF | N/A | ||
| P/OCF | 2.37 | ||
| P/B | 0.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.25 |
EPS(TTM)1.66
EY26.69%
EPS(NY)1.8
Fwd EY28.99%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.62
OCFY42.17%
SpS138.26
BVpS11.34
TBVpS-14.02
PEG (NY)0.34
PEG (5Y)1.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -5.58% | ||
| ROCE | 8.84% | ||
| ROIC | 6.98% | ||
| ROICexc | 7.09% | ||
| ROICexgc | 19.17% | ||
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 20.72% | ||
| FCFM | N/A |
ROA(3y)1.96%
ROA(5y)1.01%
ROE(3y)7.17%
ROE(5y)2.44%
ROIC(3y)8.85%
ROIC(5y)7.96%
ROICexc(3y)9.22%
ROICexc(5y)8.29%
ROICexgc(3y)18.88%
ROICexgc(5y)15.44%
ROCE(3y)11.2%
ROCE(5y)10.08%
ROICexcg growth 3Y20.85%
ROICexcg growth 5Y32.45%
ROICexc growth 3Y-4.96%
ROICexc growth 5Y14.68%
OM growth 3Y3.01%
OM growth 5Y19.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y12.59%
F-Score6
Asset Turnover2.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.36 | ||
| Cap/Depr | 78.81% | ||
| Cap/Sales | 2% | ||
| Interest Coverage | 1.78 | ||
| Cash Conversion | 36.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.45 | ||
| Altman-Z | 2.48 |
F-Score6
WACC7.14%
ROIC/WACC0.98
Cap/Depr(3y)66.67%
Cap/Depr(5y)61.64%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.74%
EPS 3Y-14.68%
EPS 5Y3.23%
EPS Q2Q%-4.55%
EPS Next Y11.12%
EPS Next 2Y15.15%
EPS Next 3Y21.66%
EPS Next 5Y15.52%
Revenue 1Y (TTM)4.22%
Revenue growth 3Y6.81%
Revenue growth 5Y1.87%
Sales Q2Q%4.95%
Revenue Next Year3.37%
Revenue Next 2Y3.58%
Revenue Next 3Y3.61%
Revenue Next 5Y5.38%
EBIT growth 1Y91.31%
EBIT growth 3Y10.02%
EBIT growth 5Y21.7%
EBIT Next Year70.93%
EBIT Next 3Y30.46%
EBIT Next 5YN/A
FCF growth 1Y-106.91%
FCF growth 3Y23.92%
FCF growth 5Y60.58%
OCF growth 1Y-29.87%
OCF growth 3Y29.74%
OCF growth 5Y44.99%